Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
veltuzumab leukocyte surface antigen leu-16 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Lupus Erythematosus
Systemic[MeSHID:D008180]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Thrombocytopenia[MeSHID:D013921]
Malignant Neoplasms[MeSHID:D009369]		 10.61 phase 2 antibody
veltuzumab leukocyte surface antigen leu-16 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Lupus Erythematosus
Systemic[MeSHID:D008180]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Thrombocytopenia[MeSHID:D013921]
Malignant Neoplasms[MeSHID:D009369]		 10.61 phase 2 unknown
veltuzumab leukocyte surface antigen leu-16 NA Successful target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Lymphoma
Non-Hodgkin[MeSHID:D008228]
Lupus Erythematosus
Systemic[MeSHID:D008180]
Chronic Lymphocytic Leukemia[MeSHID:D015451]
Thrombocytopenia[MeSHID:D013921]
Malignant Neoplasms[MeSHID:D009369]		 10.61 phase 2 inhibitor
click here to return to the previous page